(Q22306392)

ORCID Public Data File 2021

8 February 2023

J. Lindenfeld

1

JoAnn

Lindenfeld

1 reference

8 February 2023

Geraldine G Miller

Geraldine G

Miller

2

1 reference

8 February 2023

Simon F Shakar

Simon F

Shakar

3

1 reference

8 February 2023

Ronald Zolty

Ronald

Zolty

4

1 reference

8 February 2023

Brian D Lowes

Brian D

Lowes

5

1 reference

8 February 2023

Eugene E Wolfel

Eugene E

Wolfel

6

1 reference

8 February 2023

Luisa Mestroni

Luisa

Mestroni

7

1 reference

8 February 2023

Robert L 2nd Page

Robert L 2nd

Page

8

1 reference

Perspectives on cardiac allograft vasculopathy

8 February 2023

language of work or name

English

0 references

publication date

14 December 2004

0 references

published in

Circulation

0 references

volume

110

0 references

issue

24

0 references

page(s)

3734-3740

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

The utility of monoclonal antibody therapy in renal transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Tolerogenic immunosuppression for organ transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Immunosuppressive strategies in transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Lifestyle and health status in long-term cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

Post-transplant malignancy: the role of immunosuppression

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.0000149745.83186.89

7 January 2021

10.1161/01.CIR.0000149745.83186.89

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017